Home › Chronic Lymphocytic Leukemia › Michigan › Lansing
Chronic Lymphocytic Leukemia clinical trials in Lansing, MI
3 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA32 studies
- Columbus, OH29 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA21 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Chicago, IL14 studies
- Milwaukee, WI14 studies
- Cincinnati, OH14 studies
Other studies in Lansing
- Lung Cancer11 studies
- Prostate Cancer10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)7 studies
- Bladder Cancer5 studies
- Laryngeal Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Endometrial Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.